Geneoscopy announces the publication of its pivotal CRC-PREVENT trial in JAMA. The study reports that Geneoscopy’s noninvasive multi-target stool RNA (mt-sRNA) test demonstrated the highest sensitivity among available noninvasive screening tests for detecting colorectal cancer (CRC) and advanced adenomas…
